These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17335720)

  • 1. [Acute hepatitis associated with mefloquine therapy].
    Bruguera M; Herrera S
    Gastroenterol Hepatol; 2007 Feb; 30(2):102-3. PubMed ID: 17335720
    [No Abstract]   [Full Text] [Related]  

  • 2. Mefloquine-induced acute hepatitis.
    Gotsman I; Azaz-Livshits T; Fridlender Z; Muszkat M; Ben-Chetrit E
    Pharmacotherapy; 2000 Dec; 20(12):1517-9. PubMed ID: 11130224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse effects of the antimalaria drug, mefloquine: due to primary liver damage with secondary thyroid involvement?
    Croft AM; Herxheimer A
    BMC Public Health; 2002 Mar; 2():6. PubMed ID: 11914150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chlorpromazine-induced cholestatic hepatitis in intractable hiccups].
    Minondo Amuchasteguia L; Egiguren Urrosolo L; Zapata Morcillo E; Castiella Eguzkiza A
    Gastroenterol Hepatol; 2007 Feb; 30(2):103. PubMed ID: 17335721
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute psychosis after mefloquine. Report of six cases.
    Sowunmi A; Adio RA; Oduola AM; Ogundahunsi OA; Salako LA
    Trop Geogr Med; 1995; 47(4):179-80. PubMed ID: 8560592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Case of drug-induced pneumonia possibly due to mefloquine (antimalarial drug)].
    Inoue T; Tanaka E; Sakuramoto M; Minakuchi M; Maeda Y; Maniwa K; Terada K; Goto S; Takeda T; Noma S; Taguchi Y
    Nihon Kokyuki Gakkai Zasshi; 2005 Feb; 43(2):103-7. PubMed ID: 15770942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute hepatitis and atovaquone/proguanil.
    Grieshaber M; Lämmli J; Marcus L
    J Travel Med; 2005; 12(5):289-90. PubMed ID: 16256055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mefloquine-induced pneumonitis.
    Soentjens P; Delanote M; Van Gompel A
    J Travel Med; 2006; 13(3):172-4. PubMed ID: 16706949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mefloquine-induced mania in a 22-year-old Chinese man.
    Tor PC; Lee HY; Tan CH
    Singapore Med J; 2006 Jun; 47(6):549-50. PubMed ID: 16752027
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute fatty liver after malaria prophylaxis with mefloquine.
    Grieco A; Vecchio FM; Natale L; Gasbarrini G
    Lancet; 1999 Jan; 353(9149):295-6. PubMed ID: 9929030
    [No Abstract]   [Full Text] [Related]  

  • 11. Paranoid psychosis related to mefloquine antimalarial prophylaxis.
    Fuller SJ; Naraqi S; Gilessi G
    P N G Med J; 2002; 45(3-4):219-21. PubMed ID: 12968793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxycut-related Vanishing Bile Duct Syndrome.
    Adike A; Smith ML; Chervenak A; Vargas HE
    Clin Gastroenterol Hepatol; 2017 Jan; 15(1):142-144. PubMed ID: 27151488
    [No Abstract]   [Full Text] [Related]  

  • 13. Mefloquine-induced psychosis.
    Piening RB; Young SA
    Ann Emerg Med; 1996 Jun; 27(6):792-3. PubMed ID: 8644976
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug-induced hepatitis caused by Fansidar].
    Gersch K; Bröker HJ; Mörl H; Waldherr R
    Schweiz Med Wochenschr; 1987 Oct; 117(40):1544-8. PubMed ID: 3118458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary toxicity with mefloquine.
    Udry E; Bailly F; Dusmet M; Schnyder P; Lemoine R; Fitting JW
    Eur Respir J; 2001 Nov; 18(5):890-2. PubMed ID: 11757641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuropsychiatric side effects of malarial prophylaxis with mefloquine (Lariam)].
    Minei-Rachmilewitz T
    Harefuah; 1999 Jul; 137(1-2):25-7, 87. PubMed ID: 10959270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maculopathy associated with mefloquine (Lariam) therapy for malaria prophylaxis.
    Walker RA; Colleaux KM
    Can J Ophthalmol; 2007 Feb; 42(1):125-6. PubMed ID: 17361254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuro-psychiatric effects of antimalarials.
    van Riemsdijk MM; van der Klauw MM; van Heest JA; Reedeker FR; Ligthelm RJ; Herings RM; Stricker BH
    Eur J Clin Pharmacol; 1997; 52(1):1-6. PubMed ID: 9143859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and long-term psychiatric side effects of mefloquine: a follow-up on Danish adverse event reports.
    Ringqvist Å; Bech P; Glenthøj B; Petersen E
    Travel Med Infect Dis; 2015; 13(1):80-8. PubMed ID: 25435322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case study: neuropsychiatric symptoms associated with the antimalarial agent mefloquine.
    Clattenburg RN; Donnelly CL
    J Am Acad Child Adolesc Psychiatry; 1997 Nov; 36(11):1606-8. PubMed ID: 9394947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.